How Blockchain Will Change The Pharma Industry.

May 31, 2019

Pharmaceuticals are a $466 billion industry in the United States, according to Statista. However, concerns about privacy and transparency in clinical trials have the potential to impede the future of drug development and increase costs. Emerging technologies like blockchain should be explored to overcome these privacy concerns. Blockchain will greatly modernize the pharmaceutical industry, and I believe it will become the best way to handle certain initiatives that relate to transparency, privacy and traceability.At its very core, blockchain is a distributed ledger system with verifiable transactions. Through every subsequent transaction, the ledger is encrypted and verifiable throughout the chain. If there is a ledger with 100 transactions, for instance, each transaction is verifiable through its previous and subsequent transaction

Spotlight

APIFARMA - Portuguese Pharmaceutical Industry Association

The Portuguese Association of the Pharmaceutical Industry – APIFARMA - was established in 1975, and succeeds the National Guild of the Manufacturers of Medicinal Products, in order to contribute to solving the problems of the sector, for the socioeconomic development of the country, for the improvement of health in Portugal and patient access to new therapies. Currently, APIFARMA represents more than 120 companies responsible for the Production and Marketing of Medicinal Products for Human and Veterinary Use, Vaccines, and In Vitro Diagnostics.

Other Infographics
news image

Cancer Drugs Bring in Most Pharma Revenue

Infographic | February 25, 2020

Worldwide cancer drug sales are already way ahead of those of other drugs and the revenue generated by them is expected to grow even larger by 2024. This is according to a report recently released by consultancy Evaluate, which analyses trends in the pharmaceutical sector. According to Evaluate's calculations, oncology drugs reached US$123.8 billion in sales in 2018, more than double that of the next item on the list, drugs treating diabetes with US$48.5 billion dollars in sales. By 2024, cancer drug sales are expected to almost double to US$236.6 billion dollars.

Read More
news image

Pharmaceutical Industry World Economy Scenario

Infographic | May 20, 2022

This product titled One Page Pharmaceutical Industry World Economy Scenario Report Infographic PPT PDF Document is a completely editable document in A4 size designed in Powerpoint.

Read More
news image

Taking Pharmacy Benefits on a New Ride

Infographic | December 1, 2019

Rideshare companies like Uber and Lyft challenged the old way of doing things with a new approach. It’s not just about getting from point A to point B anymore, it’s about the experience, convenience and added value. The same applies to pass-through PBMs (pharmacy benefit managers) that are challenging the status quo to make prescriptions more affordable..

Read More
news image

Pharmaceutical industry and medicine

Infographic | March 12, 2022

Pharmaceutical industry and medicine vector infographics with drugs, pills, bottles and packages, text blocks and charts all around

Read More
news image

COVID-19 Summary as of March 13, 2020

Infographic | April 6, 2020

Biomedtracker and Trialtrove have a total of 307 clinical trials for the treatment of COVID-19. 152 initiated trials for the treatment of COVID-19. 155 Trials have been announced but have not yet begun recruitment.

Read More
news image

Latest Improvement on Pharmanews to Serve You Better

Infographic | April 16, 2020

Poised to give our readers and advertisers better services in spite of the COVID19 pandemic, Pharmanews–your global health journal has continued to improve on its services in terms of healthcare information dissemination, by keeping readers abreast of latest development in public health, especially on how to stay safe from the novel Coronavirus, as well as expanding our reach to over 250,000 readers per month.

Read More

Spotlight

APIFARMA - Portuguese Pharmaceutical Industry Association

The Portuguese Association of the Pharmaceutical Industry – APIFARMA - was established in 1975, and succeeds the National Guild of the Manufacturers of Medicinal Products, in order to contribute to solving the problems of the sector, for the socioeconomic development of the country, for the improvement of health in Portugal and patient access to new therapies. Currently, APIFARMA represents more than 120 companies responsible for the Production and Marketing of Medicinal Products for Human and Veterinary Use, Vaccines, and In Vitro Diagnostics.

Events